In our approach, administration of CAV-SCN1A to the hippocampus or the thalamus had a similar effect on DS epilepsy (Figures 6 and 8), consistent with an involvement of these areas in DS pathophysiology. This evidence concerns the gene SCN1A and Dravet syndrome.